Difamilast
Difamilast, sold under the brand name Moizerto among others, is a medication used for the treatment of atopic dermatitis.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Difamilast, sold under the brand name Moizerto among others, is a medication used for the treatment of atopic dermatitis. Difamilast is a non-steroidal topical phosphodiesterase 4 (PDE4) inhibitor. Difamilast was discovered and developed by Otsuka Pharmaceutical. Difamilast was approved for medical use in Japan in September 2021, and in the United States in February 2026.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1366080157 under CC BY-SA 4.0; modifications have been made.